The first vaccine trial has begun in Ebola-hit Bunia in the Democratic Republic of the Congo, marking a significant step in efforts to combat the outbreak. Health authorities and researchers are working to assess the vaccine's safety and effectiveness as concerns grow over the spread of the deadly virus. The trial could provide crucial insights for strengthening Ebola response efforts and protecting communities at risk.